Literature DB >> 18507042

Characterization of Akt overexpression in MiaPaCa-2 cells: prohibitin is an Akt substrate both in vitro and in cells.

Edward Kyu-Ho Han1, Thomas Mcgonigal, Chris Butler, Vincent L Giranda, Yan Luo.   

Abstract

Akt (PKB) is a serine/threonine protein kinase that plays an important role in the transduction of signals affecting apoptosis, cell proliferation and survival. The Akt gene is frequently hyperactivated in tumors and has been shown to be amplified in a number of types of human cancers. Furthermore, Akt activity is elevated in cell lines with the mutated PTEN tumor suppressor gene. These studies establish Akt as an attractive target for cancer therapy. To determine the roles of Akt1, Akt2 and Akt3 in signal transduction, constitutively active Akt1, Akt2 and Akt3 was ectopically overexpressed in human pancreatic MiaPaCa-2 cells. The three Akt stable clones were characterized to determine their effects on transformation and proliferation. Compared to a vector control, the three Akt clones were able to drive cellular proliferation even in reduced serum conditions. Furthermore, in soft-agar assays, the Akt clones showed an 25-38% increase in colony formation in 2% serum. Our results indicate that all three forms of Akt may have protective effects within the cell depending on the type of apoptotic stimuli. Using 2D-PAGE comparisons between parental and Akt overexpressing cells, we attempted to determine novel targets of Akt phosphorylation. In this study, we identified prohibitin as a substrate for Akt both in vitro and in vivo. These studies suggest that Akt may regulate the cellular function of prohibitin via its phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18507042

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  18 in total

1.  Isoform-specific activation of Akt involvement in hepatocarcinogenesis.

Authors:  Mohamed R Imache; Jean-Michel Pawlotsky; Hervé Lerat
Journal:  Hepat Oncol       Date:  2015-07-28

2.  Novel regulation of CD80/CD86-induced phosphatidylinositol 3-kinase signaling by NOTCH1 protein in interleukin-6 and indoleamine 2,3-dioxygenase production by dendritic cells.

Authors:  Chandana Koorella; Jayakumar R Nair; Megan E Murray; Louise M Carlson; Stephanie K Watkins; Kelvin P Lee
Journal:  J Biol Chem       Date:  2014-01-10       Impact factor: 5.157

3.  The role of lipid raft translocation of prohibitin in regulation of Akt and Raf-protected apoptosis of HaCaT cells upon ultraviolet B irradiation.

Authors:  Qiong Wu; Shiyong Wu
Journal:  Mol Carcinog       Date:  2017-03-06       Impact factor: 4.784

Review 4.  Prohibitin 1 in liver injury and cancer.

Authors:  Lucía Barbier-Torres; Shelly C Lu
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-20

Review 5.  Prohibitin - At the crossroads of obesity-linked diabetes and cancer.

Authors:  Suresh Mishra; Bl Grégoire Nyomba
Journal:  Exp Biol Med (Maywood)       Date:  2017-04-11

6.  Strain-induced proliferation requires the phosphatidylinositol 3-kinase/AKT/glycogen synthase kinase pathway.

Authors:  Christopher P Gayer; Lakshmi S Chaturvedi; Shouye Wang; David H Craig; Thomas Flanigan; Marc D Basson
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

Review 7.  Prohibitins role in cellular survival through Ras-Raf-MEK-ERK pathway.

Authors:  Indrajit Chowdhury; Winston E Thompson; Kelwyn Thomas
Journal:  J Cell Physiol       Date:  2014-08       Impact factor: 6.384

Review 8.  Multifaceted role of prohibitin in cell survival and apoptosis.

Authors:  Ya-Ting Peng; Ping Chen; Ruo-Yun Ouyang; Lei Song
Journal:  Apoptosis       Date:  2015-09       Impact factor: 4.677

9.  Prohibitin: A Novel Molecular Player in KDEL Receptor Signalling.

Authors:  Monica Giannotta; Giorgia Fragassi; Antonio Tamburro; Capone Vanessa; Alberto Luini; Michele Sallese
Journal:  Biomed Res Int       Date:  2015-05-10       Impact factor: 3.411

10.  Interaction between O-GlcNAc modification and tyrosine phosphorylation of prohibitin: implication for a novel binary switch.

Authors:  Sudharsana R Ande; Saby Moulik; Suresh Mishra
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.